Sleep apnea severity linked to glycated hemoglobin levels

June 18, 2012
Sleep apnea severity linked to glycated hemoglobin levels
For adults without diabetes, obstructive sleep apnea severity is independently associated with impaired glucose metabolism, as measured by glycated hemoglobin levels, according to a study published online June 11 in Diabetes Care.

(HealthDay) -- For adults without diabetes, obstructive sleep apnea (OSA) severity is independently associated with impaired glucose metabolism, as measured by glycated hemoglobin (HbA1c) levels, according to a study published online June 11 in Diabetes Care.

Pascaline Priou, M.D., of LUNAM University in Angers, France, and colleagues conducted a large cross-sectional study involving 1,599 patients with OSA. HbA1c levels were measured, and patients with diabetes, use of , or HbA1c levels ≥6.5 percent were excluded.

The researchers found that increased with increasing OSA severity, as measured by the apnea-hypopnea index (AHI), with the percent of patients with HbA1c increasing from 10.8 to 34.2 percent for those with AHI values <5 to ≥50, respectively. After adjusting for potential confounding factors, the odds ratios of a patient having an HbA1c level >6.0 percent increased from 1.0 (reference) for AHI <5; to 1.40 for AHI of ≥5 to <15; to 1.8 for AHI of ≥15 to <30; to 2.02 for AHI of ≥30 to <50; to 2.96 for AHI of ≥50. Additionally, an independent association was found between increasing hypoxemia during sleep and the odds of an elevated HbA1c level.

"Among adults without known diabetes, increasing OSA severity is independently associated with impaired , as assessed by higher HbA1c values, which may expose them to higher risks of diabetes and cardiovascular disease," the authors write.

Explore further: Severity of sleep disordered breathing predicts glycemic health

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Severity of sleep disordered breathing predicts glycemic health

May 23, 2012
The severity of sleep disordered breathing and nocturnal hypoxemia independently predict both glycosylated hemoglobin (HbA1c) levels and type 2 diabetes mellitus (T2DM), according to a new study.

Obstructive sleep apnea is associated with diabetic peripheral neuropathy

June 15, 2012
Obstructive sleep apnea (OSA) is independently associated with diabetic peripheral neuropathy (DPN) in patients with type 2 diabetes mellitus (T2DM), according to a new study from researchers in the UK. The severity of DPN ...

Isomaltulose doesn't improve glycemic control in diabetes

April 13, 2012
(HealthDay) -- For patients with type 2 diabetes, substitution of sucrose with isomaltulose is not associated with improved glycemic control (measured by hemoglobin A1c [HbA1c] levels) at 12 weeks, according to a study published ...

Study assesses glucose monitoring trends in tweens

April 12, 2012
(HealthDay) -- During the transition to adolescence, children with type 1 diabetes monitor their blood glucose less frequently, resulting in significant increases in HbA1c levels, according to research published online April ...

Structured exercise training associated with improved glycemic control for patients with diabetes

May 3, 2011
Implementing structured exercise training, including aerobic, resistance or both, was associated with a greater reduction in hemoglobin A1c levels (a marker of glucose control) for patients with diabetes compared to patients ...

Recommended for you

Synthetic cannabinoid reduces sleep apnea

November 29, 2017
A synthetic version of a molecule found in the cannabis plant was safe and effective in treating obstructive sleep apnea in the first large, multi-site study of a drug for the sleep disorder funded by the National Institutes ...

Sleeping through the snoring: Researchers identify neurons that rouse the brain to breathe

November 2, 2017
A common and potentially serious sleep disorder, obstructive sleep apnea affects at least one quarter of U.S. adults and is linked to increased risk of diabetes, obesity and cardiovascular disease. In a paper published today ...

Remede system approved for sleep apnea

October 9, 2017
(HealthDay)—The Remede sleep system, an implanted device that treats central sleep apnea by activating a nerve that sends signals to the diaphragm to stimulate breathing, has been approved by the U.S. Food and Drug Administration.

Inflammation may precede sleep apnea, could be treatment target

September 1, 2017
Inflammation is traditionally thought of as a symptom of sleep apnea, but it might actually precede the disorder, potentially opening the door for new ways to treat and predict sleep apnea, according to researchers.

More evidence: Untreated sleep apnea shown to raise metabolic and cardiovascular stress

August 31, 2017
Sleep apnea, left untreated for even a few days, can increase blood sugar and fat levels, stress hormones and blood pressure, according to a new study of sleeping subjects. A report of the study's findings, published in the ...

Sleep patterns contribute to racial differences in disease risk

August 18, 2017
Poor sleep patterns could explain, in part, the differences in the risk of cardiometabolic disease between African-Americans and European-Americans, according to a new study published in Proceedings of the National Academy ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.